Back to Clinical Trials

Clinical Trials: Reproductive Medicine


Source: Ferring Pharmaceuticals
To compare the ovulation rate in women with primary amenorrhea with hypogonadotropic hypogonadism following pulsatile gonadotropin-releasing hormone (GnRH) treatment using the OmniPod pump versus placebo Read More
Last Updated: 03 Oct 2016
Source: Ferring Pharmaceuticals
The purpose of this trial is to demonstrate non-inferiority of MENOPUR® versus recombinant Follicle Stimulating Hormone (rFSH) (Gonal-f®) with respect to ongoing pregnancy rate in women undergoing controlled ovarian stimulation (COS) following GnRH treatment. Read More
Last Updated: 16 Jan 2017
Source: Virginia Center for Reproductive Medicine
This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm). Read More
Last Updated: 07 Dec 2015
Source: Ferring Pharmaceuticals
The objective of this study was to compare the fertilization rate between the combination of Menopur and Bravelle mixed in the same syringe and Menopur alone, both administered subcutaneously (SC), in subjects undergoing Assisted Reproductive Technology (ART). Additionally the study assessed subjects' ability to mix and store the combination of Menopur and Bravelle and to assess safety of the Menopur and Bravelle combination. Read More
Last Updated: 05 May 2014
Source: Reproductive Medicine Associates of New Jersey
To identify the characteristics in an egg donor that are important to a recipient and to see if those characteristics change over time. Read More
Last Updated: 03 Mar 2013
Source: Reproductive Medicine Associates of New Jersey
Couples who have created excess embryos while undergoing IVF procedures, and who do not wish to transfer those embryos or donate them to another couple may donate the extra embryos to research. The embryos are then used to develop improved laboratory techniques and conditions as well as testing the proficiency of laboratory staff. Read More
Last Updated: 15 Nov 2015
Source: Dexa Medica Group
This is a 3-arm, randomized, double-blind, double-dummy, and controlled clinical study over 6 months of treatment to evaluate the metabolic and clinical efficacy as well as the safety of DLBS3233 alone, metformin and combination of both, in improving metabolic and reproductive parameters. Read More
Last Updated: 14 Nov 2016
Source: Reproductive Medicine Associates of New Jersey
To assess the impact of embryo biopsy on the reproductive potential of human embryos. Read More
Last Updated: 21 Jan 2013
Source: Reproductive Medicine Associates of New Jersey
The purpose of this study is to determine if 24 chromosome preimplantation genetic diagnosis (PGD) increases implantation and delivery rates in couples attempting to conceive through in vitro fertilization (IVF). Read More
Last Updated: 24 Mar 2015
Source: Colorado Center for Reproductive Medicine
The aim of this study is to examine the length of ovarian stimulation with the timing of trigger in an IVF cycle and its potential to impact patient outcomes. Read More
Last Updated: 08 Dec 2016
Source: Ferring Pharmaceuticals
The primary objective of this study is to determine the safety and efficacy of pulsatile GnRH delivered from a iontophoretic patch (Lutrepatch) for induction of ovulation in women with anovulatory/ oligoovulatory infertility, compared to placebo and to a reference treatment with clomiphene citrate. Read More
Last Updated: 25 Aug 2015
Source: Reproductive Medicine Associates of New Jersey
The purpose of this study is to validate the ability to assess the genetic differences (DNA fingerprinting) on polar bodies (excess genetic material given off from the egg) and cells so that this technique may be used in the future to confirm markers of reproductive competence and improve the efficiency and safety of clinical human in vitro fertilization. Read More
Last Updated: 21 Jan 2013
Source: Reproductive Medicine Associates of New Jersey
This study evaluated whether laser acupuncture at the time of embryo transfer (following in vitro fertilization) improves implantation rates. Patients were randomized to one of 4 groups at the time of embryo transfer: 1) laser acupuncture, 2) needle acupuncture, 3) sham laser acupuncture, 4) no treatment. Read More
Last Updated: 22 Jun 2016
Source: Finox AG
The purpose of this study is to show that AFOLIA, a recombinant manufactured human follicle stimulating hormone (r-hFSH) has a similar efficacy and safety profile compared to the widely used and marketed r-hFSH Gonal-f. Read More
Last Updated: 09 Feb 2016
Source: Reproductive Medicine Associates of New Jersey
The purpose of this study is to determine if sperm DNA fragmentation is associated with in vitro fertilization (IVF) outcomes when euploid embryos are transferred. Read More
Last Updated: 15 Nov 2015
Source: Virginia Center for Reproductive Medicine
This is a prospective randomized study evaluating dosing frequency of gonadotropin administration in ART cycles. Read More
Last Updated: 11 Oct 2010
Source: Reproductive Medicine Associates of New Jersey
Use of excess materials generally discarded in the process of undergoing IVF treatment to further develop and validate laboratory techniques. Read More
Last Updated: 20 Jun 2016
Source: Reproductive Medicine Associates of New Jersey
The purpose of this study is to assess the accuracy of predicting the normal or carrier status of human embryos resulting from in vitro-fertilization (IVF) from patients carrying a balanced translocation. Read More
Last Updated: 02 Oct 2016
Source: Reproductive Medicine Associates of New Jersey
To evaluate the benefits of using next generation sequencing to assess embryonic aneuploidy. All viable blastocysts will be biopsied and cryopreserved for future transfer. After the final embryo is cryopreserved, patients will be randomized to either the intervention group or the control group. Patients and doctors are blinded to the randomization until study completion. A Double Embryo Transfer (DET) will be performed with either screened or unscreened ... Read More
Last Updated: 20 Jun 2016
Source: Reproductive Medicine Associates of New Jersey
To evaluate the impact of two FDA approved culture media on potential of human embryos resulting from IVF (sequential & monophasic media). Half of each patient's embryos will be randomly assigned to grow in monophasic media & the other half in sequential media. All embryos will undergo Comprehensive Chromosome Screening (CCS) & the best euploid embryo from each group will be transferred resulting in a double embryo transfer (DET). If there are only euploid ... Read More
Last Updated: 20 Jun 2016
Page 1 of 50